Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 247-259

  Kim, Jung Lye ^a   Kang, Sang Wook ^a   Kang, Min Kyung ^a   Gong, Ju Hyun ^a   Lee, Eun Sook ^a   Han, Seoung Jun ^b   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

^b Seorim Bio   (South Korea)

Author keywords

Bone resorption; Matrix mineralization; Osteoblast; Osteoclast; Silibinin

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CATHEPSIN K; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OSTEOCLAST DIFFERENTIATION FACTOR; SILIBININ; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CALCIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; ONCOGENE SRC; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE RESORPTION; CALCIUM; CATHEPSIN K; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; ISOENZYMES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PLANT EXTRACTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SILYMARIN; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84055177046     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23351     Document Type: Article

References (43)

1. Akcakaya H, Aroymak A, Gokce S,. 2007. A quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell Biol Int 31: 186-190. (Pubitemid 46187107)
2. Al-Anati L, Essid E, Reinehr R, Petzinger E,. 2009. Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Mol Nutr Food Res 53: 460-466.
3. Arnott JA, Nuglozeh E, Rico MC, Arango-Hisijara I, Odgren PR, Safadi FF, Popoff SN,. 2007. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGFβ1-induced extracellular matrix production in osteoblasts. J Cell Physiol 210: 843-852. (Pubitemid 46185053)
4. Bu SY, Lerner M, Stoecker BJ, Boldrin E, Brackett DJ, Lucas EA, Smith BJ,. 2008. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif Tissue Int 82: 475-488.
5. Chen D, Zhao M, Mundy GR,. 2004. Bone morphogenetic proteins. Growth Factors 22: 233-241. (Pubitemid 40136452)
6. Clarke B,. 2008. Normal bone anatomy and physiology. Clin J Am Soc Nephrol (Suppl 3): S131-S139.
7. Delaisse JM, Andersen TL, Enqsuq MT, Henriksen K, Troen T, Blavier L,. 2003. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61: 504-513. (Pubitemid 36890583)
8. Fernandes JC, Shi Q, Benderdour M, Lajeunesse D, Lavigne P,. 2008. An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro. J Bone Miner Metab 26: 543-550.
9. Franceschi RT, Ge C, Xiao G, Roca H, Jiang D,. 2007. Transcriptional regulation of osteoblasts. Ann N Y Acad Sci 1116: 196-207. (Pubitemid 350274351)
10. Franco GC, Kajiya M, Nakanishi T, Ohta K, Rosalen PL, Groppo FC, Ernst CW, Boyesen JL, Bartlett JD, Stashenko P, Taubman MA, Kawai T,. 2011. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo. Exp Cell Res 317: 1454-1464.
11. Ha HL, Shin HJ, Feitelson MA, Yu DY,. 2010. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 16: 6035-6043.
12. Hadjidakis DJ, Androulakis II,. 2006. Bone remodeling. Ann N Y Acad Sci 1092: 385-396. (Pubitemid 47092355)
13. Hale LV, Ma YF, Santerre RF,. 2000. Semi-quantitative fluorescence analysis of calcein binding as a measurement of in vitro mineralization. Calcif Tissue Int 67: 80-84. (Pubitemid 30460954)
14. Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA,. 2009. Local communication on and within bone controls bone remodeling. Bone 44: 1026-1033.
15. Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS,. 2007. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J Surg Res 143: 58-65. (Pubitemid 47562449)
16. Huang W, Yang S, Shao J, Li YP,. 2007. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12: 68-92.
17. Huh YJ, Kim JM, Kim H, Song H, So H, Lee SY, Kwon SB, Kim HJ, Kim HH, Lee SH, Choi Y, Chung SC, Jeong DW, Min BM,. 2006. Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ 13: 1138-1146. (Pubitemid 43905595)
18. Imhoff BR, Hansen JM,. 2011. Differential redox potential profiles during adipogenesis and osteogenesis. Cell Mol Biol Lett 16: 49-161.
19. Jayaraj R, Deb U, Bhaskar AS, Prasad GB, Rao PV,. 2007. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environ Toxicol 22: 472-479. (Pubitemid 47435635)
20. Kang SW, Choi JS, Bae JY, Li J, Kim DS, Kim JL, Shin SY, You HJ, Park HS, Ji GE, Kang YH,. 2009. Blockade of vascular angiogenesis by Aspergillus usamii var. shirousamii-transformed Angelicae gigantis radix and Zizyphus jujube. Nutr Res Pract 3: 3-8.
21. Karsdal MA, Andersen TA, Bonewald L, Christiansen C,. 2004. Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability. DNA Cell Biol 23: 155-165. (Pubitemid 38373082)
22. Khosla S,. 2001. Minireview: The OPG/RANKL/RANK system. Endocrinology 142: 5050-5055. (Pubitemid 33131929)
23. Kim JH, Kim K, Jin HM, Song I, Youn BU, Lee J, Kim N,. 2009. Silibinin inhibits osteoclast differentiation mediated by TNF family members. Mol Cells 28: 201-207.
24. Komori T,. 2008. Regulation of bone development and maintenance by Runx2. Front Biosci 13: 898-903. (Pubitemid 351594735)
25. Kwun IS, Cho YE, Lomeda RA, Shin HI, Choi JY, Kang YH, Beattie JH,. 2010. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Bone 46: 732-741.
26. Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH,. 2010. Epigallocatechin-3- gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol 77: 17-25.
27. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH,. 2006. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 66: 4816-4825.
28. Lo YC, Chang YH, Wei BL, Huang YL, Chiou WF,. 2010. Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1cells: Involvement of BMP/Runx2 and β-catenin signals. J Agric Food Chem 58: 6643-6649.
29. Mbalaviele G, Chen H, Boyce BF, Mundy GR, Yoneda T,. 1995. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest 95: 2757-2765.
30. Miyazaki T, Tanaka S, Sanjay A, Baron R,. 2006. The role of c-Src kinase in the regulation of osteoclast function. Mod Rheumatol 16: 68-74.
31. Mokhtari MJ, Motamed N, Shokrgozar MA,. 2008. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line. Cell Biol Int 32: 888-892.
32. Pang JL, Ricupero DA, Huang S, Fatma N, Singh DP, Romero JR, Chattopadhyay N,. 2006. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem Pharmacol 71: 818-826. (Pubitemid 43208838)
33. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM,. 2003. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA 100: 3305-3310. (Pubitemid 36356578)
34. Rached MT, Kode A, Xu L, Yoshikawa Y, Paik JH, Depinho RA, Kousteni S,. 2010. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab 11: 47-160.
35. Sharma G, Singh RP, Chan DC, Agarwal R,. 2003. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res 23: 2649-2655. (Pubitemid 36897139)
36. Smerdel-Ramoya A, Zanotti S, Deregowski V, Canalis E,. 2008. Connective tissue growth factor enhances osteoblastogenesis in vitro. J Biol Chem 283: 22690-22699.
37. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV,. 2007. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313: 168-178. (Pubitemid 44958461)
38. Takayanagi H,. 2007. The role of NFAT in osteoclast formation. Ann N Y Acad Sci 1116: 227-237. (Pubitemid 350274348)
39. Tanaka Y, Nakayamada S, Okada Y,. 2005. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4: 325-328. (Pubitemid 40873119)
40. Trappoliere M, Caligiuri A, Schmid M, Bertolani C, Failli P, Vizzutti F, Novo E, di Manzano C, Marra F, Loguercio C, Pinzani M,. 2009. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 50: 1102-1111.
41. Trzeciakiewicz A, Habauzit V, Mercier S, Lebecque P, Davicco MJ, Coxam V, Demigne C, Horcajada MN,. 2010. Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J Nutr Biochem 21: 24-31.
42. Wada T, Nakashima T, Hiroshi N, Penninger JM,. 2006. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12: 17-25. (Pubitemid 43089652)
43. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y,. 1999. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cells 4: 1041-1049. (Pubitemid 30054909)